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Nonsteroidal antiinﬂammatory drugs like ibuprofen impede tissue repair by virtue of retarding inﬂammation. The present study
was undertaken to explore if linking of nitrooxyethyl ester to ibuprofen reverses its healing-depressant propensity. Nitrooxyethyl
ester of ibuprofen (NOE-Ibu) was synthesized in our laboratory through a well-established synthetic pathway. NOE-Ibu was
screened for its inﬂuence on collagenation, wound contraction and epithelialization phases of healing, and scar size of healed
wound in three wound models, namely, incision, dead space, and excision wounds. Besides, its inﬂuence on the oxidative stress
(levels of GSH and TBARS) was also determined in 10-day-old granulation tissue. NOE-Ibu was further screened for its antiin-
ﬂammatoryactivityinratpawedemamodel.NOE-Ibupromotedcollagenation(increaseinbreakingstrength,granulationweight,
and collagen content), wound contraction and epithelialization phases of healing. NOE-Ibu also showed a signiﬁcant antioxidant
eﬀect in 10-day-old granulation tissue as compared to ibuprofen. Results vindicate that the esteriﬁcation of ibuprofen with ni-
trooxyethyl group reverses the healing-suppressant eﬀect of ibuprofen. The compound also showed equipotent antiinﬂammatory
activity as ibuprofen.
Copyright © 2006 Mandeep Kaushal et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Wound repair is the eﬀort of tissues to restore normal func-
tion and structure after injury. In the initial stages, it in-
volves reformation of barriers to ﬂuid loss and infection be-
sides limiting further entry to foreign organisms and mate-
rial. Eventually, wound healing reestablishes normal blood
and lymphatic ﬂow patterns and restores mechanical in-
tegrity of the injured system. Normal wound healing follows
a predictable pattern that can be divided into overlapping
phases deﬁned by cellular populations and biochemical ac-
tivities: (a) hemostasis and inﬂammation, (b) proliferation,
and (c) maturation and remodeling.
Antiinﬂammatory agents whose principal eﬀect is to
diminish granulocytic inﬂammatory reaction also have
healing-depressant propensity [1]. Nonsteroidal antiinﬂam-
matory drugs that decrease breaking strength in incision
wounds were found to have variable eﬀects on wound con-
traction, and epithelialization [2, 3]. Ibuprofen was reported
to reduce the breaking strength of the repaired extensor ten-
don, wound contraction, and epithelialization [4–6]. Ni-
tric Oxide (NO) is a labile intercellular messenger molecule
regulating a range of physiological functions that includes
vascular tone, platelet aggregation, the immune response,
and neurotransmission in brain as well as in periphery [7].
NO is also involved in pathogenesis of acute and chronic in-
ﬂammatory conditions. Mast cells, which release a number
of mediators like histamine and 5-hydroxytryptamine, also
produceNO[8].ExogenousNOcanhowevermodulatemast
cells degranulation, which could therefore act as a feedback
inhibitor [9, 10]. Findings from rat model of edema evoked
by carrageenan suggest that e-NOS is involved in the devel-
opment of this acute inﬂammatory response, whereas iNOS
is involved in maintenance of the inﬂammatory response
[11–13]. NO has been reported to be involved in the angio-
genic mechanisms of activated macrophages since inhibitors
of NOS cause an inhibition of macrophage-dependent an-
giogenesis [14].
The nitric oxide (NO) donating compound, isosorbide-
5-mononitrate, has been found to reverse the mucosal dam-
aging eﬀect of castor oil [15, 16]. Inhibitors of NO exer-
bate the gastric mucosal injury caused by indomethacin.
The conversion of some acidic NSAIDs like ﬂubriprofen to
their nitrooxyethyl esters has resulted in reduction in gastric2 Mediators of Inﬂammation
ulcerogenicity without any concomitant decrease in antiin-
ﬂammatory activity [17].
Since inﬂammation is a prelude to wound healing and
NO is a mediator in inﬂammation and a potent angiogenic
factor [14, 16, 18, 19], the present work was planned to see if
linkingofanNOdonortoibuprofencouldreversethelatter’s
inﬂuence on healing, yet retaining its original antiinﬂamma-
tory eﬀect. So the study was carried out to compare the ef-
fects of nitrooxyethyl ester of ibuprofen (NOE-Ibu) with re-
specttoitsparentmolecule(Ibu)ondiﬀerentwoundmodels
and to appraise its eﬀects on an acute inﬂammatory model.
MATERIAL AND METHODS
Reagentsandchemicals
Ibuprofen [(RS)-2-(4-isobutylphenyl) propionic acid] was
purchased from Arora Pharmaceuticals (Delhi, India). Ben-
zene, P-toluene sulphonic acid, silica gel, n-propanol, and
sodium sulphate were obtained from Qualigens Fine Chemi-
cals (Mumbai, India). Reduced glutathione (GSH) and hy-
droxyproline (OHP) were purchased from Sigma Aldrich
(Bangalore, India). Nitrooxyethyl ester of ibuprofen (NOE-
Ibu) (C15H21N1O5) was synthesized in our laboratory
through a well-established synthetic pathway and its struc-
ture was established through analytical and spectral data.
Animals
Healthy inbred male albino rats of Wistar strain weigh-
ing between 180g and 200g were used for the study. They
were individually housed in sterile polypropylene cages and
maintained on normal food and water adlibitum. No ex-
ternal or internal chemotherapeutic cover was provided to
the animals except the drugs under test. The surgical in-
terventions were carried out under ketamine anaesthesia
(10mg/kg). All experimental procedures were carried out in
accordancewiththeguidelinesofInstitutionalAnimalEthics
Committee.
Druganddosing
Animalsweredividedintothreegroupseachhavingeightan-
imals. While control group received 4% suspension of gum
Acacia, the second and third groups received ibuprofen (in
the dose of 200mg/kg) and NOE-Ibu (300mg/kg), respec-
tively. The drug solutions that were suspended using a 4%
gum Acacia and the vehicle were administered in the volume
of 5mL/kg. The dose of Ibu was arrived at by computing the
minimum human dose to rat based on the surface area. The
dose of NOE-Ibu contained equal amount of Ibu that was
given to group two animals.
Incisionwoundmodel
Thismodelwasemployedtodeterminethebreakingstrength
of incision wound in rats as per the methods described by
Ehrlich et al [20–22]. Two paravertabral straight-line inci-
sions were made on either side of the vertebral column on
the shaven back of the animals. Wounds were closed with
intermittent sutures of 1cm apart. Animals were treated
daily with drugs from 0th to 9th postwounding day. Su-
tures were removed on 7th postwounding day and wound
breaking strength was estimated on 10th postwounding
day by constant water ﬂow technique as described by Lee
[1].
Excisionwoundmodel
Theparameterssuchaswoundcontraction,epithelialization,
scar size, and histopathology were monitored in this wound
model.UsingAccupunchof10mmdiameter,afull-thickness
skin was excised to get a wound measuring 79mm [2] in the
fur clipped dorsal thoracic central region, 5cm away from
the ears of anaesthetized rats. After achieving full hemosta-
sis, animals were placed in their individual cages. Animals
received drugs daily from 0th day to 21st postwounding
day or until the healing was complete, whichever was ear-
lier.
Woundcontraction
The wound contraction was calculated as percentage of the
original wound size (79mm [2]) for each animal of a group
and group mean was calculated on predetermined days,
namely, days 4, 6, 8, 10, 12, 14, and 16 for ﬁnal analysis of
results.
Periodofepithelialization
Falling of scab, leaving no raw wound behind, was taken as
the endpoint of complete epithelialization and the days re-
quired for this were taken as the period of epithelialization.
Scararea
Scar area was measured by tracing the intact healed wound
area on tracing paper on the ﬁnal day when there seemed to
be no visible change in the wound area and the wound had
completely healed and closed.
Histopathologicalevaluation
On day 10, a small piece of the intact healed wound with
e d g e sw a se x c i s e df r o ma na n i m a lo fe a c hg r o u pa n dﬁ x e d
in 10% neutral buﬀered formalin. Histopathological evalua-
tion was carried using Hematoxylin & Eosin (H & E) stained
5–6μ thin paraﬃn longitudinal sections.
Deadspacewoundmodel
This method is usually employed for assessing the ex-
tent of collagenation. The dead space wound was created
by implanting subcutaneous 2.5 × 0.5cm polypropyleneMandeep Kaushal et al 3
tubes of two numbers in the lumbar region on dorsal side
[23]. Animals received drugs from 0th day to 9th post-
wounding day. On 10th postwounding day, granulation tis-
sue harvested on each implanted tube was carefully dis-
sected out along with the tube and employed for determi-
nation of breaking strength. While one tubegranulation was
used for the estimation of hydroxyproline (OHP), the other
tubegranulation was used to determine the levels of reduced
glutathione (GSH) and thiobarbituric acid reactive species
(TBARS).
Determinationofbreakingstrengthof
granulation
tissue
A piece of granulation tissue was ﬁxed between two Babcock
forceps and its breaking strength was measured by a constant
and continuous water ﬂow technique.
Determinationofdrygranulationweight
The granulation tissue was collected and dried at 60◦Cf o r2 4
hours to get constant weight and was weighed.
Estimationofhydroxyproline
The dry granulation tissues were digested using 6N HCl and
the neutral hydrolysate was used to estimate the content of
hydroxyproline by the method of Neuman and Logan (1950)
(see [24]).
Estimationofreducedglutathione(GSH)
GSH contents were determined in the granulation tissue by
the method of Okhawa et al [27].
Estimationofthiobarbituricacidreactivesubstances
Malonialdehyde formed from the breakdown of polyunsatu-
rated fatty acids serves as a convenient index for determining
the extent of peroxidation reaction. Malondialdehyde is the
product of lipid peroxidation that reacts with thiobarbituric
acid to give red species absorbing at 535nm [26].
Carrageenin-inducedratpawedema
ThemethodofWinteretal(1962)wasusedwithslightmod-
iﬁcations. Rats were dosed orally with NOE-Ibu and ibupro-
fen drugs at calculated doses. One hour after drug admin-
istration, subplantar injection of 0.05mL of 1% suspension
of carrageenan was performed. The paw volumes, immedi-
ately after injection (0th hours volume) and 3 hours after in-
jection (3rd hour volume), were measured using plethysmo-
graph. The diﬀerence between the 0th hour paw volume and
3rd hour paw volume gave edema volume, which was further
used to calculate percentage of inhibition.
Statisticalanalysis
One-way ANOVA followed by Scheﬀe’s post hoc test using
SPSS computer package analyzed results.
RESULTS
Breakingstrengthof10-day-oldincisionand
deadspacewounds
Breaking strengths of 10-day-old incision and dead space
woundsinthecontrolgroupofanimalswere357gand271g,
respectively. Ibuprofen signiﬁcantly (P<. 05) reduced the
strengths of the scars of incision and the granulation tissues
of the dead space wounds as compared to that of control
group. On the other hand, nitrooxyethyl ester of ibuprofen
signiﬁcantly promoted the strengths of the healed wounds
as compared to Ibuprofen and control. It is clear from the
ﬁndings that ibuprofen depressed breaking strength while
nitrooxyethyl ester of ibuprofen did not do this. In fact, it
increased the breaking strength of incision wound (Figure 1
and Table 1).
Biochemicalattributesofgranulationtissuesof
deadspacewounds
(i)Collagencontent
The concentration of hydroxyproline (a marker of colla-
gen content) present in 10-day-old granulation tissue (dead
space wound) in control group of animals was 27.5mg/g,
while it was 13.3 m g / gi ni b u p r o f e n - t r e a t e dg r o u p( as i g -
niﬁcant P<. 05 reduction compared to control). On the
other hand, the collagen content in nitrooxyethyl ester of
ibuprofen-treated animals was found to be 43.4mg/g, which
was signiﬁcantly (P<. 05) more than that of ibuprofen
as well as control group of animals values. A trend similar
to that seen in the changes of collagen content in diﬀerent
groups of animals was seen in the dry granulation weights as
well (Table 2).
(ii)Oxidativestressparameters
The levels of thiobarbituric acid reactive substance (TBARS)
in granulation tissue of control group animals was 3.98
μM/g. This was signiﬁcantly (P<. 05) increased with the
treatment of ibuprofen to an extent of four folds. This indi-
cated an oxidative stress induction with ibuprofen (Table 1).
However, it increased the levels of reduced glutathione
(GSH) signiﬁcantly (P<. 05) as compared to control.
Nitrooxyethyl ester ibuprofen, on the other hand, reduced
the level of TBARS as compared to that of parent compound
and the control group. Further, it increased the levels of GSH
signiﬁcantly (P<. 05) more than that of the parent com-
pound and the control group (Table 2).4 Mediators of Inﬂammation
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Figure 1: Eﬀect of drugs on breaking strength of 10-day-old incision wound. Each bar represents mean ± SEM. Control animals were
administered 4% suspension of gum Acacia at dose 5mL/kg, Ibu group received 200mg/kg of ibuprofen and NOE-Ibu received 300mg/kg
nitrooxyethyl ester of ibuprofen. Mean value of 8 animals gave the breaking strength of the given group.
Table 1: Wound models employed and parameters monitored.
Wound model Drug treatment Parameter monitored Remarks
Incision wound
(for collagenation phase)
From 0th–9th
postwounding
day
Breaking strength
Suture removed on the 7th postwounding day,
breaking strength measurement on the 10th
postwounding day
Excision wound
(for the wound contraction,
epithelialization and scar size)
From 0th–21st
postwounding day
Wound contraction, period of Measured as % of the original wound size,
epithelialization, scar size, calculated as number of days taken for the fall
histopathology of of scab with no raw wound remaining,
granulation tissue scar area on the day of completed healing
Dead space wound
From 0th–9th
Granulation breaking
Parameters measured on the day 10
postwounding postwounding day
strength, dry granulation
weight, hydroxyproline
estimation and antioxidation
studies in the granulation
tissue (GSH and TBARS)
Woundcontractionofexcisionwound
The rate of wound contraction in the animals that received
vehicle (control) was 26%, 71%, and 90%, respectively, by
day 4, day 8, and day 12. However, the wound contrac-
tion was signiﬁcantly (P<. 05) low in animals that re-
ceived ibuprofen as compared to control. This was reversed
by NOE-Ibu administration (Figure 2).
Epithelizationandscarsizeofexcisionwound
The control group animals took 17 days for reepitheliza-
tion. These animals had a scar size of 4.5sq mm. Ibuprofen
signiﬁcantly (P<. 05) prolonged the period of epitheliza-
tion by four days; besides the animals had bigger scar area
than the control group of animals. The nitrooxyethyl-ester-
linked ibuprofen not only reversed the healing-depressant
propensity of ibuprofen on epithelialization, but also short-
ened the period of epithelialization by 3 days. The scar size
in these animals was almost similar to that of control group
animals (Table 3).
Carrageenin-inducedratpawedema
In carrageenin-induced rat paw edema, model of inﬂam-
mation, NOE-Ibu showed similar antiinﬂammatory activity
as compared to that of its parent drug, namely, ibuprofen
(Table 4).
Histopathologicalevaluation
The length of the epithelial tongue from the wound margin
in a control animal section was 772.5μm. Besides, the sec-
tion had fully grown dermis that was rich in collagen withMandeep Kaushal et al 5
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Figure 2: Eﬀect of drugs on wound contraction. Contraction was studied by tracing the raw wound area on tracing paper on predetermined
days, namely, days 4, 6, 8, 10, 12, 14, and 16 or till completion of healing, whichever was earlier. Ibuprofen group has signiﬁcantly (P<. 05)
lesser contraction than control group. NOE-ibuprofen has signiﬁcantly (P<. 05) more contraction than ibuprofen.
Table 2: Eﬀect of ibuprofen and its NOE on the granulation tissues of 10-day-old dead space wounds (by Scheﬀes test—SPSS computer
package). (OHP = orthohydroxyproline, GSH = reduced glutathione, TBARS =thiobarbituricacidreactivespecies,n = number of animals).
The diﬀerence between any two means is statistically signiﬁcant if the mean diﬀerence is more than the allowance value calculated.
Group (n) Dose Granulation breaking Dry granulation OHP GSH TBARS
(mg/kg) strength(g) weight (g) mg/g (μg/g) (μM/g)
Control (8) — 271 ±15.53 2 .6 ±32 7 .5 ±2.27 .08 ±1.30 3.98 ±0.60
Ibuprofen (7) 200 157 ±9.9a 16.3 ±2.11 3 .3 ±2.4a 34.87 ±5.44a 11.24 ±1.40a
NOE-Ibu (7) 300 403 ±12.4a,b 65.4 ±6.5a,b 43.4 ±3.2a,b 45.20 ±4.30a,b 2.25 ±0.20a,b
a = P<. 05 versus control.
b = P<. 05 versus ibuprofen.
moderate number of inﬂammatory cells and blood vessels. A
notable feature of Ibu section was that of a shorter-length
epithelial tongue as compared to control, about 515μm.
Other features seen were fully grown dermis with poorly
organized collagen. Except for the length of the epithelial
tongue, all other features of NOE-Ibu-treated wound section
were similar to that of control. The length of the epithelium
in this case was 927μm( Figure 3).
DISCUSSION
Wound healing is a symphony of biological processes, ini-
tiated by tissue injury that culminates in restoration of tis-
sue integrity. The end result of the repair process is ﬁbro-
sis and scar in all organ systems except bone and special-
ized conditions of liver injury. Wound healing is the sum-
mation of a number of processes that follow injury; these
includecoagulation,inﬂammation,andmatrixsynthesisand
deposition. These are followed by angiogenesis, ﬁbroplasias,
epithelialization, contraction, remodeling, and scar matura-
tion. NSAIDs are one amongst such groups of agents that
retard healing on their pre- and postsurgical administra-
tion to reduce pain and inﬂammation [1–3]. Diﬀerent ap-
proaches have been made to overcome the negative eﬀects
of NSAIDs on healing without compromising their antiin-
ﬂammatory and analgesic activities. For instance, zinc and
copper have been linked coordinately with NSAIDs to de-
velop coordinate compounds [23, 24]. The present study is
also aimed at that direction—the development of an NOE-
NSAID. An idea worth contemplating stemmed from the
ﬁndings that nitrooxyethyl derivatives (NO donors) and the
NO that is released from the activated macrophages have a
pivotal role in the pathophysiology of wound healing [25].
Besides this, some reports indicate that NOE-linked NSAIDs6 Mediators of Inﬂammation
Table 3: Eﬀect of ibuprofen and NOE-ibuprofen on epithelialization and scar size (by Scheﬀe’s test—SPSS computer package). (n =
number of animals.) The diﬀerence between any two means is statistically signiﬁcant if the mean diﬀerence is more than the allowance
value calculated.
Group (n) Dose Epithelization period (days) Scar size (mm2)
(mg/kg) (mean ± SE) (mean ± SE)
Control (7) — 17.85 ±0.63 4.57 ±0.48
Ibuprofen (7) 200 22.66 ± 1.08a 11.33 ±0.88a
NOE-Ibu (7) 300 14.71 ±0.42a,b 3.71 ±0.77b
a = P<. 05 versus control.
b = P<. 05 versus ibuprofen.
(a) (b) (c)
Figure 3:Photomicrographshowinggranulationtissueinterspersedwithcollagen(H&E ×100)of(a)controlgroup,of(b)ibuprofengroup,
and (c) treated with NOE-Ibu.
have better antiinﬂammatory activity and less gastric irri-
tancypropensity thantheirparentNSAIDs[27].Thus,inthe
present study nitrooxyethyl ester of ibuprofen was developed
and compared with its parent compound for its inﬂuence on
wound healing and inﬂammation.
Results of the study showed that the NOE-Ibu promoted
collagenation(increaseinbreakingstrengthofskinandgran-
ulation tissue; increase in granulation weight and collagen
content), wound contraction, and epithelialization phases of
healing, while ibuprofen had healing-depressant propensity
on all the phases of healing as compared to that of control.
Antiinﬂammatory eﬀect of NOE-Ibu in paw edema test was
equivalent to that of ibuprofen.
Results of the study vindicated our assumption that link-
ing of NO donors to ibuprofen would have prohealing ac-
tivity. The macrophage is the one cell that is truly cen-
tral to wound healing, serving to orchestrate the release of
proinﬂammatory cytokines (TNF-α, IL-1, IL-6, IL-8, INF-
γ), growth factors (PDGF, TGF-β, EGF, TGF-α, FGF, IGF-
1), and other chemicals. One amongst them is NO. Nitric
oxide activates angiogenesis, acts as a chemotactic to ﬁbrob-
lasts, and promotes ﬁbroplasias [25]. All these may con-
tribute to the promotion of collagenation phase of healing.
Nitric oxide is known for its antioxidant potential. In our
study, ibuprofen enhanced the MDA (marker of oxidative
stress) levels in the granulation tissue, besides raising the
GSH levels. The elevated GSH should have neutralized the
oxidative stress that was induced by ibuprofen but it did not
happen in this situation. Perhaps the levels of GSH in this
case might not have been suﬃcient to do the same. In case
of the treatment with NOE-Ibu, the level of MDA was re-
duced. This could perhaps be due to the result of a drastic
rise in the levels of GSH and the presence of NO (antiox-
idant by itself) in the structures of NOE-Ibu. The antiox-
idant property of this molecule thus could also have con-
tributed to the prohealing actions of this molecule. This as-
sumption has got the basis that the oxidative stress is detri-
mental to the reparative process and some antioxidants are
reported to have promoted the healing [17, 28, 29]. Bene-
ﬁcial eﬀects of NO on wound repair may be attributed to
its functional inﬂuence on angiogenesis, inﬂammation, cell
proliferation,matrixdeposition,andmodulationofcytokine
cascade.
However, it is very diﬃcult to pinpoint the exact mech-
anism of the prohealing properties of NOE-Ibu, as the heal-
ing process is very complex and complicated involving many
signaling pathways, chemicals, and so forth, that would link
diﬀerent phases of healing. Besides, some of the phases of
healing such as wound contraction and epithelialization run
concurrently and independently.
Whatever the mechanism of action of NOE-Ibu be, the
prohealing action of the compound so identiﬁed through
the present study may make this molecule very sound and
promising in surgical wound management than its parentMandeep Kaushal et al 7
Table 4: Eﬀect of ibuprofen and its NOE on carrageenin-induced rat paw edema (by Scheﬀe’s test—SPSS computer package). (n =
number of animals.) The diﬀerence between any two means is statistically signiﬁcant if the mean diﬀerence is more than the allowance
value calculated.
Group (n) Dose Edema volume (mL) % decrease in
(mg/kg) (mean ± SE) edema volume
Control (8) — 0.40 ±0.009
Ibuprofen (8) 200 0.13 ±0.010a 66.5 ±2.67
NOE-Ibu (8) 300 0.12 ±0.012a 69.37 ±3.08
a = P<. 05 versus control.
drug. Pre- and postsurgical administration of NOE-Ibu
would have the same antiinﬂammatory action and most im-
portantly, it would not have the risk of healing impairment.
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